{
  "meta": {
    "title": "Lymphomas",
    "url": "https://brainandscalpel.vercel.app/lymphomas-52b2db60.html",
    "scrapedAt": "2025-11-30T08:49:11.112Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab monotherapy</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">R-CHOP chemotherapy</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">High-dose methotrexate</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">CAR-T cell therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents with painless lymphadenopathy and occasional fever. A biopsy shows diffuse large B-cell lymphoma (DLBCL). What is the most appropriate first-line treatment?</span></p>",
      "unique_key": "DT1295040",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone)</strong> is the standard first-line therapy for DLBCL, offering curative outcomes in 60-65% of patients.</li>\r\n<li><strong>Rituximab monotherapy</strong> is not sufficient for aggressive lymphomas like DLBCL.</li>\r\n<li><strong>High-dose methotrexate</strong> is used in CNS prophylaxis for high-risk cases but not as the primary therapy.</li>\r\n<li><strong>CAR-T cell therapy</strong> is reserved for relapsed/refractory cases after multiple lines of treatment.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>R-CHOP remains the cornerstone treatment for newly diagnosed DLBCL.</li>\r\n<li>CAR-T cell therapy is emerging for relapsed/refractory DLBCL.</li>\r\n</ul>\r\n",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Epstein-Barr virus (EBV)</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Human T-cell leukemia virus type 1 (HTLV-1)</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Helicobacter pylori</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Campylobacter jejuni</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old woman with a history of gastric MALT lymphoma reports dyspepsia. Which infectious agent is most commonly associated with this condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501073fcdea5c-3011-4097-8d5d-122482f687a5.jpg\"></span></p>",
      "unique_key": "DT1295223",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295223,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Helicobacter pylori</strong> infection is strongly associated with gastric MALT lymphoma and can lead to regression of the lymphoma with antibiotic therapy.</li>\r\n<li><strong>Epstein-Barr virus (EBV)</strong> is associated with Burkitt lymphoma and aggressive NHLs in immunocompromised patients.</li>\r\n<li><strong>HTLV-1</strong> is linked to adult T-cell lymphoma, especially in Japan and the Caribbean.</li>\r\n<li><strong>Campylobacter jejuni</strong> is associated with certain intestinal NHL subtypes but not gastric MALT lymphoma.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>H. pylori is a significant causative factor in gastric MALT lymphoma and is often treated with antibiotics.</li>\r\n<li>Other infections associated with NHL include EBV and HTLV-1.</li>\r\n</ul>\r\n",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">t(14;18)</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">t(8;14)</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">t(11;14)</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">t(2;5)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man presents with abdominal pain and a rapidly enlarging abdominal mass. Biopsy confirms Burkitt lymphoma. Which genetic translocation is commonly associated with this condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107d77cb35d-4ed1-4e67-8f1f-ab9416d8c432.jpg\"></span></p>",
      "unique_key": "DT1295224",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295224,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>t(8;14) translocation</strong> involves the MYC gene and the immunoglobulin heavy chain locus, a hallmark of Burkitt lymphoma.</li>\r\n<li><strong>t(14;18)</strong> is associated with follicular lymphoma involving BCL2.</li>\r\n<li><strong>t(11;14)</strong> is seen in mantle cell lymphoma involving cyclin D1 (CCND1).</li>\r\n<li><strong>t(2;5)</strong> is characteristic of anaplastic large cell lymphoma involving ALK.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Burkitt lymphoma is characterized by MYC gene translocations, typically t(8;14).</li>\r\n<li>This lymphoma is highly aggressive but responsive to prompt chemotherapy.</li>\r\n</ul>\r\n",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Indicates low-grade lymphoma</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Suggests aggressive disease and correlates with high tumor metabolism</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Is specific for lymphoma only</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Is used solely for diagnosis and not for prognosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man with diffuse large B-cell lymphoma (DLBCL) undergoes a PET-CT. The scan shows multiple FDG-avid lymph nodes. What is the significance of FDG avidity in this context?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501074613c725-f145-491e-b253-4ee665945a1c.jpg\"></span></p>",
      "unique_key": "DT1295225",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295225,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>FDG avidity</strong> on PET-CT is common in aggressive lymphomas like DLBCL, reflecting high metabolic activity.</li>\r\n<li><strong>Low-grade lymphomas</strong> typically show lower FDG uptake.</li>\r\n<li>PET-CT is not specific to lymphoma and can be used to assess response to therapy and guide prognosis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>PET-CT is crucial for staging, response assessment, and prognosis in aggressive lymphomas.</li>\r\n<li><strong>FDG uptake correlates with tumor aggressiveness </strong>and can guide management.</li>\r\n</ul>\r\n",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and R are true, and R is the correct explanation of A.</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and R are true, but R is not the correct explanation of A.</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">A is true, but R is false.</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">A is false, but R is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Assertion (A): Burkitt lymphoma requires immediate initiation of treatment due to its rapid progression.<br>Reason (R): Burkitt lymphoma has a high proliferation rate with a doubling time of less than 24 hours.</span></p>",
      "unique_key": "DT1295226",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295226,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Burkitt lymphoma is one of the fastest-growing human tumors with a doubling time of less than 24 hours, necessitating urgent treatment.</li>\r\n<li>The rapid progression is due to the high proliferation rate, which supports the need for immediate initiation of combination chemotherapy.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501078ede5195-e0b6-49f9-a1f0-c8d3a017b482.jpg\">\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Burkitt lymphoma is a medical emergency due to its aggressive nature.</li>\r\n<li>Early recognition and prompt treatment are critical for improving outcomes.</li>\r\n</ul>\r\n",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">PET/CT scan</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male presents with painless lymphadenopathy in the neck and mediastinum. Biopsy shows classical Hodgkin lymphoma (cHL) with Reed-Sternberg cells positive for CD15 and CD30. Which imaging modality is preferred for staging in this patient?</span></p>",
      "unique_key": "DT1295227",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295227,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>PET/CT is the preferred imaging modality for staging Hodgkin lymphoma due to its accuracy in detecting nodal and extranodal disease.</li>\r\n<li>CT scans are less specific as they do not provide metabolic activity data.</li>\r\n<li>MRI is useful for CNS involvement but not routine for HL staging.</li>\r\n<li>Ultrasound has limited use in staging HL.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>PET/CT provides comprehensive staging information and is crucial for treatment planning in HL.</li>\r\n</ul>\r\n",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">B symptoms</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Paraneoplastic symptoms</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Pel-Ebstein fever</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic symptoms</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old woman with newly diagnosed Hodgkin lymphoma reports weight loss, fever, and night sweats. What is the term used to describe these symptoms?</span></p>",
      "unique_key": "DT1295228",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295228,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>B symptoms include <strong>unexplained weight loss, fever, and night sweats</strong> and are significant in staging and prognostication of Hodgkin lymphoma.</li>\r\n<li>Paraneoplastic symptoms can occur in various cancers but are not specific to HL.</li>\r\n<li>Pel-Ebstein fever is a rare cyclical fever associated with HL.</li>\r\n<li>Systemic symptoms are a general term not specific to HL.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>B symptoms are crucial for staging and impact treatment decisions in Hodgkin lymphoma.</li>\r\n</ul>\r\n",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuropathy</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary malignancies</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Infertility in men</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male with Hodgkin lymphoma is treated with ABVD chemotherapy. What is a significant late complication associated with this treatment?</span></p>",
      "unique_key": "DT1295229",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Late complications of Hodgkin lymphoma treatment include secondary malignancies, especially solid tumors and leukemia, due to radiation and chemotherapy.</li>\r\n</ul>\r\n<p>Option C: Infertility is common in men treated with alkylating agents but is rare with ABVD.</p>\r\n<p>Option D: Hypothyroidism is associated with neck radiation.</p>\r\n<p>Option A: Neuropathy is less common but may occur due to vinblastine.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Secondary malignancies are a major concern in HL survivorship, particularly in those treated with radiation.</li>\r\n</ul>\r\n",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">To confirm the diagnosis</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">To detect metastasis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">To assess response to treatment</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">To guide biopsy site selection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old male diagnosed with advanced-stage classical Hodgkin lymphoma (cHL) receives ABVD chemotherapy. What is the role of interim PET/CT scans in his management?</span></p>",
      "unique_key": "DT1295230",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295230,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Interim PET/CT scans after 2-3 cycles of chemotherapy help assess response and guide further treatment decisions in HL.</li>\r\n<li>PET/CT is not used for diagnosis but for staging and monitoring.</li>\r\n<li>Detection of metastasis is part of initial staging.</li>\r\n<li>Biopsy site selection is usually based on clinical findings.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Interim PET/CT is crucial for response assessment and may alter the course of treatment.</li>\r\n</ul>\r\n",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and R are true, and R is the correct explanation of A.</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and R are true, but R is not the correct explanation of A.</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">A is true, but R is false.</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">A is false, but R is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Assertion (A): Reed-Sternberg cells are diagnostic for classical Hodgkin lymphoma.<br>Reason (R): Reed-Sternberg cells express CD15 and CD30, which aid in diagnosis.</span></p>",
      "unique_key": "DT1295231",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Reed-Sternberg cells are the hallmark of HL and are characterized by CD15 and CD30 positivity, aiding in the diagnosis.</li>\r\n<li>These markers help differentiate HL from other lymphomas.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The presence of Reed-Sternberg cells with CD15 and CD30 is critical for HL diagnosis.</li>\r\n</ul>\r\n",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Allogeneic stem cell transplantation</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Autologous stem cell transplantation</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Maintenance therapy with nivolumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male with relapsed Hodgkin lymphoma is considered for salvage therapy. What is the next step if he responds well to salvage chemotherapy?</span></p>",
      "unique_key": "DT1295232",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295232,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Autologous stem cell transplantation is the standard curative approach for patients responding to salvage chemotherapy in relapsed Hodgkin lymphoma</strong>.</li>\r\n<li>Allogeneic transplantation is considered if autologous fails.</li>\r\n<li>Maintenance therapy is used in specific cases, usually post-transplant.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>High-dose chemotherapy followed by autologous stem cell transplant is the mainstay in relapsed HL with favorable response to salvage therapy.</li>\r\n</ul>\r\n",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">6 cycles of ABVD alone</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">4 cycles of ABVD followed by radiation therapy</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiation therapy alone</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Brentuximab vedotin monotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old man with early-stage favorable Hodgkin lymphoma (stage IIA) undergoes treatment. What is the recommended standard of care?</span></p>",
      "unique_key": "DT1295233",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295233,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Combined-modality therapy (4 cycles of ABVD followed by radiation)</strong> is the standard for early-stage favorable Hodgkin lymphoma, reducing relapse rates.</li>\r\n<li>ABVD alone is considered in certain cases, but combined therapy offers a better progression-free survival.</li>\r\n<li>Radiation alone is insufficient for systemic disease control.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Combined-modality therapy remains the gold standard in early-stage favorable HL to minimize recurrence.</li>\r\n</ul>\r\n",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue ABVD for 4 additional cycles</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch to radiation therapy alone</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Intensify to BEACOPP regimen</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop treatment and observe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old patient with Hodgkin lymphoma has a negative interim PET/CT scan after 2 cycles of ABVD. What is the next best step?</span></p>",
      "unique_key": "DT1295234",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295234,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>A negative interim PET/CT suggests a good response, allowing continuation of the current regimen (ABVD) to complete 6 cycles.</li>\r\n<li>Intensifying to BEACOPP is not needed with a negative PET scan.</li>\r\n<li>Radiation is not used alone in systemic disease.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Negative interim PET/CT supports continuing the current chemotherapy regimen in Hodgkin lymphoma.</li>\r\n</ul>\r\n",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Poor prognosis</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Higher likelihood of relapse</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased treatment resistance</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">No significant impact on prognosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male with HIV-associated classical Hodgkin lymphoma shows positive Epstein-Barr virus (EBV) markers. What is the implication of EBV positivity in this patient?</span></p>",
      "unique_key": "DT1295235",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295235,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>EBV positivity in HIV-associated Hodgkin lymphoma is linked with worse outcomes and reflects a higher burden of immunosuppression.</strong></li>\r\n<li>This association necessitates close monitoring and possibly more aggressive therapy.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>EBV positivity is a poor prognostic marker in HIV-associated Hodgkin lymphoma.</li>\r\n</ul>\r\n",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">ABVD chemotherapy</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiation therapy to the neck</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">PD-1 inhibitors</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroid therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old female undergoes treatment for classical Hodgkin lymphoma and develops hypothyroidism. What is the likely cause?</span></p>",
      "unique_key": "DT1295236",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295236,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Neck radiation commonly causes hypothyroidism due to damage to the thyroid gland.</strong></p>\r\n<p>Option A: Chemotherapy regimens like ABVD have minimal thyroid effects.</p>\r\n<p>Option C: PD-1 inhibitors can cause thyroid dysfunction but are less likely in this scenario.</p>\r\n<p>Option D: Steroids do not directly cause hypothyroidism.</p>\r\n<p><strong>Key Takeaways:</strong> Thyroid monitoring is crucial for patients receiving neck radiation in Hodgkin lymphoma.</p>\r\n ",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">A2, B1, C3, D4</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">A1, B3, C4, D2</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">A4, B1, C2, D4</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">A3, B2, C1, D4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the Lymphoma Subtypes with their Chromosomal Translocations<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501072c144368-8637-4199-81d4-a28f4633b710.jpg\"></span></p>",
      "unique_key": "DT1295237",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295237,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Burkitt Lymphoma:</strong> Characterized by the t (8;14) translocation involving the MYC gene.</li>\r\n<li><strong>Mantle Cell Lymphoma:</strong> Associated with t (11;14), leading to overexpression of cyclin D1.</li>\r\n<li><strong>Follicular Lymphoma:</strong> Commonly involves the t (14;18) translocation with the BCL2 gene.</li>\r\n<li><strong>Diffuse Large B-Cell Lymphoma:</strong> Frequently associated with BCL6 rearrangements such as t (3;14).</li>\r\n</ul>\r\n ",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">A2, B4, C3, D1</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">A3, B2, C4, D1</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">A1, B4, C2, D3</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">A1, B3, C2, D4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the Lymphoma Treatments with Their Specific Indications<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107d8481629-e6e7-4ada-8298-5ad9095164d0.jpg\"></span></p>",
      "unique_key": "DT1295238",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295238,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>ABVD:</strong> Standard regimen for early-stage classical Hodgkin lymphoma.</li>\r\n<li><strong>R-CHOP:</strong> Standard treatment for DLBCL.</li>\r\n<li><strong>Brentuximab Vedotin:</strong> CD30-directed antibody-drug conjugate used in relapsed/refractory HL.</li>\r\n<li><strong>Escalated BEACOPP:</strong> Used for advanced-stage HL, especially with PET-positive findings.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">A2, B1, C3, D4</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">A1, B2, C3, D4</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">A2, B3, C1, D4</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">A4, B3, C2, D1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the Diagnostic Markers with the Type of Lymphoma<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250107458fce99-0068-4cf1-b4bc-b828841e4218.jpg\"></span></p>",
      "unique_key": "DT1295239",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295239,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>CD15, CD30:</strong> Diagnostic markers for classical Hodgkin lymphoma, particularly Reed-Sternberg cells.</li>\r\n<li><strong>CD10, BCL6:</strong> Common markers in Burkitt lymphoma.</li>\r\n<li><strong>CD19, CD20, BCL2:</strong> Markers associated with follicular lymphoma, reflecting B-cell lineage and anti-apoptotic properties.</li>\r\n<li><strong>CD3, CD4, PD-1:</strong> Markers typical for Peripheral T-cell lymphomas.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">A2, B1, C3, D4</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">A1, B3, C4, D2</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">A2, B3, C2, D1</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">A4, B2, C1, D3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the Common Risk Factors with the Associated Lymphoma Types<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501079081c616-65a9-499e-bf30-fbc8b73fda87.jpg\"></span></p>",
      "unique_key": "DT1295240",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295240,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>H. pylori Infection:</strong> Strongly associated with gastric MALT lymphoma.</li>\r\n<li><strong>HTLV-1 Infection:</strong> Leads to Adult T-cell leukemia/lymphoma, common in endemic areas like Japan and the Caribbean.</li>\r\n<li><strong>EBV:</strong> Frequently seen in classical Hodgkin lymphoma, especially in immunocompromised settings.</li>\r\n<li><strong>HIV Infection:</strong> Increases risk for aggressive NHLs, including Burkitt lymphoma.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}